PDF) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
PDF) High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
Immunosuppression following heart transplantation: prospects and challenges | Immunotherapy
Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection - ScienceDirect
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer - eBioMedicine
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Cancer Risk Among Immunosuppressed Populations - NCI
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - eBioMedicine
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
